Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares Sold by Silver Oak Securities Incorporated

Silver Oak Securities Incorporated cut its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 3.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 21,574 shares of the company’s stock after selling 859 shares during the quarter. Silver Oak Securities Incorporated’s holdings in Alignment Healthcare were worth $241,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in ALHC. Creative Planning raised its holdings in Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company’s stock worth $147,000 after purchasing an additional 2,072 shares during the last quarter. R Squared Ltd acquired a new position in shares of Alignment Healthcare during the 4th quarter worth $55,000. SG Americas Securities LLC boosted its position in shares of Alignment Healthcare by 11.7% in the 4th quarter. SG Americas Securities LLC now owns 49,272 shares of the company’s stock worth $554,000 after buying an additional 5,163 shares in the last quarter. nVerses Capital LLC acquired a new stake in Alignment Healthcare in the 3rd quarter valued at about $95,000. Finally, The Manufacturers Life Insurance Company increased its holdings in Alignment Healthcare by 20.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 55,531 shares of the company’s stock valued at $434,000 after acquiring an additional 9,595 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Stock Performance

Alignment Healthcare stock opened at $14.74 on Monday. The stock has a fifty day moving average price of $12.77 and a 200 day moving average price of $11.44. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $15.82. The firm has a market capitalization of $2.83 billion, a P/E ratio of -19.14 and a beta of 1.50. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

Insider Buying and Selling at Alignment Healthcare

In related news, insider Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction on Friday, November 15th. The stock was sold at an average price of $11.35, for a total value of $340,500.00. Following the transaction, the insider now owns 1,696,097 shares in the company, valued at approximately $19,250,700.95. This trade represents a 1.74 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Sebastian Burzacchi sold 8,550 shares of the company’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $11.26, for a total value of $96,273.00. Following the sale, the chief operating officer now owns 217,395 shares of the company’s stock, valued at $2,447,867.70. This represents a 3.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 371,124 shares of company stock worth $4,654,981 in the last 90 days. 6.60% of the stock is owned by company insiders.

Analyst Ratings Changes

Several analysts have issued reports on ALHC shares. Stifel Nicolaus upped their price target on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a report on Tuesday, January 14th. UBS Group upped their target price on Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research note on Wednesday, October 30th. Stephens reissued an “overweight” rating and set a $17.00 price target on shares of Alignment Healthcare in a research report on Thursday, January 2nd. Finally, Barclays upped their price objective on Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.